Panagora Asset Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.43M | Sell |
104,776
-16,766
| -14% | -$604K | 0.01% | 521 |
|
|
2026
Q1 | $4.3M | Buy |
121,542
+10,875
| +10% | +$442K | 0.02% | 444 |
|
|
2025
Q4 | $4.49M | Buy |
110,667
+27,199
| +33% | +$1.18M | 0.02% | 412 |
|
|
2025
Q3 | $3.93M | Buy |
+83,468
| New | +$4.33M | 0.02% | 398 |
|
|
2022
Q4 | – | Sell |
-13,684
| Closed | -$1.1M | – | 1444 |
|
|
2022
Q3 | $1.1M | Sell |
13,684
-54,558
| -80% | -$5.15M | 0.01% | 822 |
|
|
2022
Q2 | $6.54M | Buy |
68,242
+11,528
| +20% | +$1.38M | 0.04% | 327 |
|
|
2022
Q1 | $8.43M | Sell |
56,714
-85,944
| -60% | -$12M | 0.05% | 311 |
|
|
2021
Q4 | $20.2M | Sell |
142,658
-924
| -0.6% | -$131K | 0.11% | 183 |
|
|
2021
Q3 | $18.8M | Sell |
143,582
-484
| -0.3% | -$63.3K | 0.1% | 196 |
|
|
2021
Q2 | $19.8M | Buy |
144,066
+35,159
| +32% | +$4.81M | 0.11% | 195 |
|
|
2021
Q1 | $14.2M | Sell |
108,907
-18,759
| -15% | -$2.26M | 0.08% | 233 |
|
|
2020
Q4 | $14.3M | Buy |
127,666
+11,871
| +10% | +$1.12M | 0.08% | 214 |
|
|
2020
Q3 | $9.11M | Sell |
115,795
-13,807
| -11% | -$1.13M | 0.06% | 260 |
|
|
2020
Q2 | $9.33M | Buy |
129,602
+10,319
| +9% | +$718K | 0.06% | 266 |
|
|
2020
Q1 | $6.83M | Sell |
119,283
-80,148
| -40% | -$7.39M | 0.05% | 287 |
|
|
2019
Q4 | $22.3M | Buy |
199,431
+16,288
| +9% | +$1.74M | 0.1% | 213 |
|
|
2019
Q3 | $17.6M | Sell |
183,143
-19,069
| -9% | -$1.79M | 0.08% | 224 |
|
|
2019
Q2 | $17.3M | Sell |
202,212
-9,643
| -5% | -$793K | 0.08% | 242 |
|
|
2019
Q1 | $17.6M | Buy |
211,855
+31,329
| +17% | +$2.28M | 0.08% | 251 |
|
|
2018
Q4 | $11.6M | Buy |
180,526
+12,111
| +7% | +$829K | 0.05% | 286 |
|
|
2018
Q3 | $13.3M | Buy |
168,415
+47,240
| +39% | +$3.65M | 0.05% | 302 |
|
|
2018
Q2 | $8.87M | Buy |
121,175
+83,155
| +219% | +$5.66M | 0.04% | 375 |
|
|
2018
Q1 | $2.41M | Buy |
38,020
+30,314
| +393% | +$1.81M | 0.01% | 804 |
|
|
2017
Q4 | $393K | Sell |
7,706
-15,121
| -66% | -$788K | ﹤0.01% | 1446 |
|
|
2017
Q3 | $1.2M | Buy |
22,827
+9,029
| +65% | +$453K | ﹤0.01% | 1053 |
|
|
2017
Q2 | $703K | Buy |
+13,798
| New | +$683K | ﹤0.01% | 1250 |
|
|
2016
Q3 | – | Sell |
-23,602
| Closed | -$1.13M | – | 2416 |
|
|
2016
Q2 | $1.13M | Hold |
23,602
| – | – | 0.01% | 1081 |
|
|
2016
Q1 | $990K | Sell |
23,602
-370
| -2% | -$14.5K | ﹤0.01% | 1102 |
|
|
2015
Q4 | $1.06M | Hold |
23,972
| – | – | 0.01% | 1037 |
|
|
2015
Q3 | $1.14M | Buy |
23,972
+1,594
| +7% | +$87.5K | 0.01% | 984 |
|
|
2015
Q2 | $1.3M | Buy |
22,378
+339
| +2% | +$18.3K | 0.01% | 976 |
|
|
2015
Q1 | $1.11M | Sell |
22,039
-2,820
| -11% | -$138K | 0.01% | 1022 |
|
|
2014
Q4 | $1.12M | Sell |
24,859
-10,983
| -31% | -$460K | 0.01% | 1000 |
|
|
2014
Q3 | $1.32M | Buy |
35,842
+22,657
| +172% | +$899K | 0.01% | 916 |
|
|
2014
Q2 | $582K | Sell |
13,185
-5,879
| -31% | -$267K | ﹤0.01% | 1326 |
|
|
2014
Q1 | $828K | Hold |
19,064
| – | – | ﹤0.01% | 1255 |
|
|
2013
Q4 | $810K | Hold |
19,064
| – | – | ﹤0.01% | 1241 |
|
|
2013
Q3 | $648K | Sell |
19,064
-9,089
| -32% | -$297K | ﹤0.01% | 1270 |
|
|
2013
Q2 | $879K | Buy |
+28,153
| New | +$914K | ﹤0.01% | 1106 |
|
Other funds holding CNMD
ICM
Panagora Asset Management's CNMD Position: Q2 2026 in Review
Panagora Asset Management reduced its CONMED (CNMD) stake by 14% in Q2 2026, selling an estimated $604K and leaving 104,776 shares worth $3.43M. The position accounts for 0.01% of the portfolio, ranked #521.
Panagora Asset Management first reported a position in CNMD in Q2 2013 and has held it in 39 quarters since. The position peaked at $22.3M in Q4 2019. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Panagora Asset Management held 104,776 shares of CONMED worth $3.43M as of Q2 2026.
- Panagora Asset Management sold 16,766 CONMED shares in Q2 2026, an estimated $604K.
- CONMED made up 0.01% of Panagora Asset Management's portfolio in Q2 2026, its #521 holding.
- Panagora Asset Management first reported a position in CONMED in Q2 2013 and has held it in 39 quarters since.
- Panagora Asset Management's CONMED position peaked at $22.3M in Q4 2019.
- 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.